Baxter International Inc. (BAX) reported that net income and revenue remained the same as last year’s second quarter as the company saw a 1% decrease in sales in U.S. sales.
The provider of dialysis products had $343 million in net income, or 66 cents a share, compared with 63 cents a share at this time last year. Analysts polled by FactSet estimated earnings of 75 cents a share.
Baxter reported $2.84 billion in sales, the same as last year’s quarter. Analysts polled by FactSet estimated sales of $2.79 billion.
The company guided sales growth of 3% to 4% for the third quarter and estimated earnings at 75 cents to 78 cents a share.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.